Search

everythinglearnresearchcommunity

for

Search:↓

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

Minoxidil sulfate relaxes muscle by increasing potassium flow, making it a unique muscle relaxer.

A new treatment for hair loss shows promise with fewer side effects.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

Evidence-based urology improved treatment and quality of life for conditions like BPH by shifting from surgery to effective medications like finasteride and dutasteride.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

Dutasteride 0.5mg was found to be more effective than finasteride 1mg in treating male pattern hair loss, with similar side effects.

Finasteride may improve prostate cancer treatment outcomes.

Finasteride treatment makes the prostate look more like a healthy one.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Tamsulosin and solifenacin together effectively reduce symptoms in BPH patients.

Tamsulosin increases the risk of floppy iris during eye surgery.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

KATP channels are important for energy balance and are targeted by drugs for diabetes, hypoglycemia, hypertension, and hair loss.